The Colorado Department of Public Health and Environment has awarded $2.7 million in grant funding for two research studies to investigate the potential therapeutic uses of marijuana.
Both research studies are random controlled trials, the type of research considered to be the “gold standard” in the scientific community. One study will research marijuana as a treatment for chronic spine pain and will evaluate its use as a therapy to reduce prescription opioid use. The other will research the efficacy and safety of cannabidiol (CBD) to treat children with autism spectrum disorder.
The state already has funded $9 million in medical marijuana research grants and an additional $2.35 million in grants for seven marijuana public health research studies. Earlier this year, the General Assembly authorized the department’s Medical Marijuana Research Grant Program to fund and oversee a new round of medical marijuana research grants through June 2023. In an executive order, Gov. John Hickenlooper directed the department to prioritize fiscal resources to research the use of medical marijuana by patients experiencing autism spectrum disorder. In addition, the reduction or elimination of long-term opioid use for chronic pain has been an ongoing priority for the department, and important questions remain about whether marijuana can be an effective substitute for opioids.
The grants were awarded following scientific review and scoring of 13 preliminary applications that were received. Each study will be awarded $1,350,000 to fund the research over three years. The approved grants are:
Approved medical marijuana research grants
Colorado Cannabis Research Consortium (C2RC): Research Program for the Management of Chronic Spine Pain and Reduction of Prescription Opioid Use
Emily Lindley, Ph.D.
Assistant Professor, Department of Orthopedics, University of Colorado Anschutz
Rachael Rzasa Lynn, M.D.
Department of Anesthesiology,
University of Colorado Anschutz
A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Cannabidiol (CBD) for the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorder (ASD)
Johnny Green is a cannabis activist from Oregon. Johnny has a bachelor's degree in public policy, and believes that the message should always be more important than the messenger. #LegalizeIt #FreeThePlant
By Spencer Ward The Colorado Department of Public Health and Environment (CDPHE) has changed how retail and medical marijuana products will warn people they contain THC. After an October 2017 regulation requiring different symbols for different products, the Marijuana Enforcement Division (MED) and CDPHE have settled on a single, universal [read more]
A Denver jury has rejected a civil complaint that sought to use federal anti-racketeering (RICO) laws as a mechanism to shut down licensed marijuana operators. Plaintiffs in the lawsuit, which was initially backed by the anti-drug organization Safe Streets Alliance, argued that the presence of a nearby licensed marijuana retailer was detrimental [read more]
Cannabis prohibitionists have been known to lie, from the early days of Harry Anslinger’s to the continued Reefer Madness of today, led by the likes of Sheldon Adelson, Maine Governor Paul LePage and Project SAM. The so-called quarterback of the prohibitionists, SAM Director Kevin Sabet, was just caught lying to Massachusetts [read more]